Patents by Inventor D. Christopher SCHELLING

D. Christopher SCHELLING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NK ANTAGONISTS FOR CONTRACEPTION
    Publication number: 20230338355
    Abstract: The present disclosure relates generally to a method for preventing pregnancy in a female patient and to a method of chemically castrating a male patient.
    Type: Application
    Filed: July 30, 2021
    Publication date: October 26, 2023
    Inventor: D. Christopher SCHELLING
  • NK RECEPTOR ANTAGONISTS FOR CANCER PATIENTS
    Publication number: 20230277518
    Abstract: The present disclosure relates generally to a method of blocking, attenuating, or limiting the development of one or more vasomotor symptoms (VMS) in a patient who has cancer, has had cancer, or has an increased risk for cancer by administering a NK antagonist.
    Type: Application
    Filed: July 30, 2021
    Publication date: September 7, 2023
    Inventors: Robert A. STEINER, D. Christopher SCHELLING, Susan D. REED, Victor M. NAVARRO
  • METHODS OF ADMINISTERING TASTE MASKED PHENYLBUTYRATE AND COMPOSITIONS THEREFOR
    Publication number: 20230248657
    Abstract: The present invention provides taste masked formulations of phenylbutyrate and methods of use in treatment nitrogen retention and other disorders. Formulations of the invention also reduced CNS adverse events and allow for longer consumption times.
    Type: Application
    Filed: July 7, 2021
    Publication date: August 10, 2023
    Inventor: D. Christopher SCHELLING
  • PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF
    Publication number: 20230133629
    Abstract: The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of metabolism (e.g., Maple Syrup Urine Disease or Urea Cycle Disorders), neurodegenerative disorders such as Parkinson's disease, spinal muscular atrophy, dystonia, or inclusion-body myositis with such compositions.
    Type: Application
    Filed: September 2, 2022
    Publication date: May 4, 2023
    Inventors: Leah E. APPEL, Joshua R. SHOCKEY, D. Christopher SCHELLING
  • METHODS OF TREATING UREA CYCLE DISORDERS AND MAPLE SYRUP URINE DISEASE
    Publication number: 20210220304
    Abstract: The present invention provides methods for the treatment of urea cycle disorders and Maple Syrup Urine Disease.
    Type: Application
    Filed: March 9, 2021
    Publication date: July 22, 2021
    Inventors: Leah E. APPEL, Joshua R. SHOCKEY, D. Christopher SCHELLING
  • PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF
    Publication number: 20210186908
    Abstract: The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of metabolism (e.g., Maple Syrup Urine Disease or Urea Cycle Disorders), neurodegenerative disorders such as Parkinson's disease, spinal muscular atrophy, dystonia, or inclusion-body myositis with such compositions.
    Type: Application
    Filed: March 9, 2021
    Publication date: June 24, 2021
    Inventors: Leah E. APPEL, Joshua R. SHOCKEY, D. Christopher SCHELLING
  • PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF
    Publication number: 20200261385
    Abstract: The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of metabolism (e.g., Maple Syrup Urine Disease or Urea Cycle Disorders), neurodegenerative disorders such as Parkinson's disease, spinal muscular atrophy, dystonia, or inclusion-body myositis with such compositions.
    Type: Application
    Filed: January 17, 2020
    Publication date: August 20, 2020
    Inventors: Leah E. APPEL, Joshua R. SHOCKEY, D. Christopher SCHELLING
  • PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF
    Publication number: 20170266115
    Abstract: The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of metabolism (e.g., Maple Syrup Urine Disease or Urea Cycle Disorders), neurodegenerative disorders such as Parkinson's disease, spinal muscular atrophy, dystonia, or inclusion-body myositis with such compositions.
    Type: Application
    Filed: October 17, 2016
    Publication date: September 21, 2017
    Inventors: Leah E. APPEL, Joshua R. SHOCKEY, D. Christopher SCHELLING